On the diagnostic side, we encountered a challenge where the ETV6::ABL1 was obscured during the MPN phase, only to be detected late during the blast phase, which significantly delayed early diagnostic suspicion of MLN-TK and its corresponding treatment. This evidence concerns the gene ABL1 and myeloproliferative neoplasm.